Cargando…

Self-guided virtual reality therapy for social anxiety disorder: a study protocol for a randomized controlled trial

BACKGROUND: Social anxiety disorder (SAD) is a highly prevalent mental disorder associated with enormous stress and suffering. Cognitive behavior therapy (CBT) is the first-line treatment for SAD, yet its accessibility is often constrained with long waiting times. Digital therapeutic applications, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hildebrand, Anne Sophie, Roesmann, Kati, Planert, Jari, Machulska, Alla, Otto, Esra, Klucken, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097393/
https://www.ncbi.nlm.nih.gov/pubmed/35549980
http://dx.doi.org/10.1186/s13063-022-06320-x
_version_ 1784706168195645440
author Hildebrand, Anne Sophie
Roesmann, Kati
Planert, Jari
Machulska, Alla
Otto, Esra
Klucken, Tim
author_facet Hildebrand, Anne Sophie
Roesmann, Kati
Planert, Jari
Machulska, Alla
Otto, Esra
Klucken, Tim
author_sort Hildebrand, Anne Sophie
collection PubMed
description BACKGROUND: Social anxiety disorder (SAD) is a highly prevalent mental disorder associated with enormous stress and suffering. Cognitive behavior therapy (CBT) is the first-line treatment for SAD, yet its accessibility is often constrained with long waiting times. Digital therapeutic applications, including psychoeducation and self-guided behavioral experiments in virtual reality (VR), could facilitate access and reduce waiting times. The study aims to investigate if ultra-short-time therapy involving self-guided digital therapeutic applications with VR components can reduce the severity of SAD. METHODS: Forty SAD patients will participate in this randomized controlled trial. Half will get access to a self-guided, digital therapeutic application with exposure-based behavioral experiments in VR, while the other half will receive a control treatment. Both treatments include four therapeutic appointments. Changes in the severity of SAD will be measured after each appointment and on a 6-week follow-up assessment and will be compared between groups, with the change in SAD measured at baseline- and post-assessment as primary outcome. DISCUSSION: Self-guided digital therapeutic applications including ultra-short-time therapy combined with VR could help reduce the waiting time for patients and relieve the health system. The results of this study may inform psychotherapists regarding the potential of self-guided digital therapeutic applications including exposure-based behavioral experiments in VR for SAD and will provide important insight for future research on VR therapy. TRIAL REGISTRATION: Current Controlled Trials ISRCTN18013983. Registered on 1 February 2022.
format Online
Article
Text
id pubmed-9097393
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90973932022-05-13 Self-guided virtual reality therapy for social anxiety disorder: a study protocol for a randomized controlled trial Hildebrand, Anne Sophie Roesmann, Kati Planert, Jari Machulska, Alla Otto, Esra Klucken, Tim Trials Study Protocol BACKGROUND: Social anxiety disorder (SAD) is a highly prevalent mental disorder associated with enormous stress and suffering. Cognitive behavior therapy (CBT) is the first-line treatment for SAD, yet its accessibility is often constrained with long waiting times. Digital therapeutic applications, including psychoeducation and self-guided behavioral experiments in virtual reality (VR), could facilitate access and reduce waiting times. The study aims to investigate if ultra-short-time therapy involving self-guided digital therapeutic applications with VR components can reduce the severity of SAD. METHODS: Forty SAD patients will participate in this randomized controlled trial. Half will get access to a self-guided, digital therapeutic application with exposure-based behavioral experiments in VR, while the other half will receive a control treatment. Both treatments include four therapeutic appointments. Changes in the severity of SAD will be measured after each appointment and on a 6-week follow-up assessment and will be compared between groups, with the change in SAD measured at baseline- and post-assessment as primary outcome. DISCUSSION: Self-guided digital therapeutic applications including ultra-short-time therapy combined with VR could help reduce the waiting time for patients and relieve the health system. The results of this study may inform psychotherapists regarding the potential of self-guided digital therapeutic applications including exposure-based behavioral experiments in VR for SAD and will provide important insight for future research on VR therapy. TRIAL REGISTRATION: Current Controlled Trials ISRCTN18013983. Registered on 1 February 2022. BioMed Central 2022-05-12 /pmc/articles/PMC9097393/ /pubmed/35549980 http://dx.doi.org/10.1186/s13063-022-06320-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Study Protocol
Hildebrand, Anne Sophie
Roesmann, Kati
Planert, Jari
Machulska, Alla
Otto, Esra
Klucken, Tim
Self-guided virtual reality therapy for social anxiety disorder: a study protocol for a randomized controlled trial
title Self-guided virtual reality therapy for social anxiety disorder: a study protocol for a randomized controlled trial
title_full Self-guided virtual reality therapy for social anxiety disorder: a study protocol for a randomized controlled trial
title_fullStr Self-guided virtual reality therapy for social anxiety disorder: a study protocol for a randomized controlled trial
title_full_unstemmed Self-guided virtual reality therapy for social anxiety disorder: a study protocol for a randomized controlled trial
title_short Self-guided virtual reality therapy for social anxiety disorder: a study protocol for a randomized controlled trial
title_sort self-guided virtual reality therapy for social anxiety disorder: a study protocol for a randomized controlled trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097393/
https://www.ncbi.nlm.nih.gov/pubmed/35549980
http://dx.doi.org/10.1186/s13063-022-06320-x
work_keys_str_mv AT hildebrandannesophie selfguidedvirtualrealitytherapyforsocialanxietydisorderastudyprotocolforarandomizedcontrolledtrial
AT roesmannkati selfguidedvirtualrealitytherapyforsocialanxietydisorderastudyprotocolforarandomizedcontrolledtrial
AT planertjari selfguidedvirtualrealitytherapyforsocialanxietydisorderastudyprotocolforarandomizedcontrolledtrial
AT machulskaalla selfguidedvirtualrealitytherapyforsocialanxietydisorderastudyprotocolforarandomizedcontrolledtrial
AT ottoesra selfguidedvirtualrealitytherapyforsocialanxietydisorderastudyprotocolforarandomizedcontrolledtrial
AT kluckentim selfguidedvirtualrealitytherapyforsocialanxietydisorderastudyprotocolforarandomizedcontrolledtrial